Form 4 Filing for Tammenoms Bakker Juliet

This filing details a transaction by Tammenoms Bakker Juliet, a director at Rx Sight, Inc. On June 17, 2026, Juliet Tammenoms Bakker acquired 37,037 shares of Common Stock through a transaction coded as "A", with a reported price of $0.0 per share. Following this transaction, the post-transaction shares owned are 85,183. Additionally, the filing notes that 1,548 shares are held in trust, with Juliet Tammenoms Bakker acting as the Investment Trustee and potentially sharing voting, investment, and dispositive power. The filing also includes a Power of Attorney document, appointing specific individuals to act on behalf of the undersigned in executing and filing required reports with the SEC and other relevant entities. This Power of Attorney remains in effect until no longer required for filings related to the company's securities, unless earlier revoked.